ASCVD risk score
Biomarker3 papers3 findings
- Human trial2
- Humans1
Interventions
1Semaglutide
downin humans1−33%Moderate certainty
1 study
Semaglutide
downin humans1−33%Moderate certainty
Semaglutide decreases ASCVD risk score in humans (-32.6%).
Human trialin people with HIV with lipohypertrophy32 weeks
Effects of semaglutide on subclinical cardiovascular health in people with HIV · AIDS (London, England) · 17 Sep 2026
Upstream
1Erythritol
downin humans1
1 study
Erythritol
downin humans1
Erythritol decreases ASCVD risk score in humans (β: -0.16%; SE: 0.07%).
Human trialper 1 SD reduction, in response to weight-loss dietary interventions6 mon = 664
Declines in plasma erythritol and improvements in cardiovascular risk and atherogenic lipid profiles: a 2-year randomized weight-loss dietary intervention trial · The American journal of clinical nutrition · 18 Sep 2026
Associations
1Cardiovascular disease
upin humans1
1 study
Cardiovascular disease
upin humans1
ASCVD risk score predicts cardiovascular disease in humans (AUC 0.927 (95% CI: 0.87-0.98)).
Humansin people living with HIV in Bogotá, Colombia10 yearsn = 911
Validation of cardiovascular risk scores in people living with HIV in Colombia · Enfermedades infecciosas y microbiologia clinica (English ed.) · 5 Sep 2026